[PDF][PDF] 不同MAPP 量对心脏瓣膜置换手术患者肺功能保护及凝血功能的影响

刘芳, 李彩霞, 韩新, 王发兴 - 临床血液学杂志, 2023 - lcxyen.whuhzzs.com
目的: 探讨不同改良自体血小板分离(MAPP) 量对心脏瓣膜置换手术患者肺功能保护及凝血功能
的影响. 方法: 纳入2019 年1 月—2023 年1 月医院住院成人心脏瓣膜病95 …

Application of rotational thromboelastometry in patients with acute promyelocytic leukemia

N Sabljic, N Pantic, M Virijevic… - Clinical and Applied …, 2022 - journals.sagepub.com
Introduction Hemorrhagic early death (HED) remains a major cause of treatment failure
among patients with acute promyelocytic leukemia (APL). We aimed to investigate the …

Hemostatic conditions following autologous transfusion of fresh vs stored platelets in experimental endotoxemia: an open-label randomized controlled trial with …

SF van Wonderen, FLF van Baarle… - Research and Practice …, 2024 - Elsevier
Background Platelet increment is reportedly lower for maximum stored platelet concentrates
(PCs) and during pyrexia, and in vitro function differs between fresh and stored PCs …

Postoperative bleeding after dentoalveolar surgery in patients with thrombocytopenia—are prophylactic platelet transfusions necessary?

J Lundström, S Wiqvist, M Jädersten, V Tollemar… - Supportive Care in …, 2024 - Springer
Purpose Benefits of prophylactic platelet (PLT) transfusion before dentoalveolar surgery are
unclear. This study investigated the effect of prophylactic PLT transfusions on the incidence …

Improving platelet function following prophylactic platelet transfusion in patients with hematological malignancies

YF Wu, CL Shen, WH Huang, SC Chu… - International Journal …, 2024 - Wiley Online Library
Introduction Platelet transfusion is a standard treatment to prevent bleeding in patients with
hematological malignancies. Although transfusions can improve platelet count, their impact …

Mechanism of abnormal coagulation induced by tigecycline in cancer patients

LH Sun, KH Bai, GY Wu, XP Tian, ZQ Zou… - Frontiers in …, 2022 - frontiersin.org
Tigecycline is a broad-spectrum active intravenous antibiotic that is active against methicillin-
resistant staphylococcus aureus. In Phase 3 and 4 clinical trials, increased all-cause …

阿伐曲泊帕联合rhTPO 在恶性血液病自体造血干细胞移植中的临床疗效分析

明静, 丁凯阳, 胡茂贵, 王馨辰 - 临床输血与检验, 2024 - lcsxyjy.com
目的观察阿伐曲泊帕联合重组人血小板生成素(rhTPO) 对恶性血液病自体造血干细胞移植(
ASCT) 后血小板(PLT) 植入的临床疗效. 方法回顾性分析76 例ASCT 患者的临床资料, 其中40 …

Clinical efficacy of avatrombopag and recombinant human thrombopoietin in the treatment of chronic liver disease-associated severe thrombocytopenia: A real-world …

YS Wang, W Wang, S Zhang, SY Zhang… - Frontiers in …, 2022 - frontiersin.org
Purpose: To investigate the clinical efficacy of avatrombopag, an oral thrombopoietin
receptor agonist, versus subcutaneous recombinant human thrombopoietin (rh-TPO) in the …

Nomogram for the Therapeutic Efficacy of Apheresis Platelet Transfusion in Hematologic Patients

Y He, H Feng, L Yu, G Deng - Indian Journal of Hematology and Blood …, 2024 - Springer
This study aims to explore the factors that affect the efficacy of apheresis platelet transfusion
in patients with hematologic diseases and construct a nomogram prediction model to predict …

Efficacy of Avatrombopag Combined with rhTPO for Thrombocytopenia Treatment in Patients with Hematologic Malignancies after Autologous Hematopoietic Stem …

M Jing, D Kaiyang, HU Maogui… - JOURNAL OF CLINICAL …, 2024 - lcsxyjy.com
Objective To observe efficacy of avatrombopag (AVA) combined with recombinant human
thrombopoietin (rhTPO) on platelet (PLT) engraftment in patients with hematological …